Skip to content

Significance of MAIT Cells in Inflammatory Bowel Disease

Significance and Biological Importance of Mucosal Associated Invariant T Cells in Inflammatory Bowel Disease Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05598346
Enrollment
70
Registered
2022-10-28
Start date
2023-03-01
Completion date
2024-04-30
Last updated
2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Diseases

Keywords

Mucosal Associated Invariant T Cells

Brief summary

To examine the level and function of MAIT cells in IBD patients, and to compare it with disease activity.

Detailed description

Inflammatory bowel diseases (IBDs), including ulcerative colitis (UC) and Crohn's disease (CD), are chronic inflammatory diseases of unknown origin. IBD has become a global disease with increasing incidence in newly industrialized and westernized countries. Genetic and environmental factors with inadequate host immune response to gut flora appear to play important roles in the pathogenesis of IBD. Adaptive immune response has been classically considered to play a major role in IBD pathogenesis . Infiltrating lymphocytes including T helper (Th) 1 cells and Th17 cells can lead to the development of intestinal lesions . However, recent evidences suggest that innate immune response is equally important in inducing gut inflammation . Altered epithelial barrier function and aberrant innate immune responses contribute to intestinal inflammation in IBD patients. Mucosal-associated invariant T (MAIT) cells are innate lymphocytes that express a conserved invariant Tcell receptor (TCR) Vα7.2-Jα33 chain paired with a limited set of Vβ chains. Using distinct pairs of TCR chains, MAIT cells can recognize bacteria-derived riboflavin (vitamin B2) metabolites presented by MHC(major histocompatibility complex) class 1b-like related protein (MR1). Upon MR1-dependent recognition of antigens, MAIT cells are activated to rapidly release Th1/Th17 proinflammatory cytokines (i.e., interferon \[IFN\]-γ, tumor necrosis factor \[TNF\]-α, and interleukin \[IL\]-17 and cytotoxic molecules (i.e.,granzyme and perforin) to kill infected host cells. MAIT cells are abundant in peripheral blood where they where they express gut-homing chemokine receptors such as CCR6(chemokine receptor type 6) and CCR9(chemokine receptor type9). They are also abundant in intestinal mucosa where they likely confront normal flora or pathogenic bacteria producing bacterial ligands. Given tissue- homing properties and rapid production of proinflammatory cytokines, MAIT cells may play an important role in infectious diseases and autoimmune disorders. Results from experiment with transfer of MAIT cells to TNBS(trinitrobenzene sulfonic acid)-induced IBD murine models suggest that MAIT cells might play a protective role in TNBS-induced intestinal inflammation . In addition, previous studies have reported MAIT cell dysfunction in IBD patients. However, the role of MAIT cells in IBD patients remains unclear.

Interventions

None listed

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
15 Years to 50 Years

Inclusion criteria

* Patients with active IBD according to clinical scores with the following: 1. Recently discovered. 2. Average age (15-50).

Exclusion criteria

* Patient with history of any of the following ; 1. History of respiratory disorders such as chronic obstructive diseases, pulmonary disease or pulmonary embolism. 2. Other Autoimmune diseases, infectious diseases. 3. Recent surgery, malignancies, left ventricular dysfunction, use of immunosuppressive drugs. 4. Chronic liver, renal, and endocrine diseases.

Design outcomes

Primary

MeasureTime frameDescription
Detection of MAIT cells level in IBD,Compare its level with disease activityBaselineMonoclonal Antibodies by flow cytometry used for detection of MAIT cells in IBD patients

Contacts

Primary ContactAL- shimaa mohamed salahidden
shoshomylife86@gmail.com01010328330
Backup Contactwael Ahmed Abbas
01064236064

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026